Baseline Characteristics of Participants in the ASPREE (ASPirin in Reducing Events in the Elderly) Study

BACKGROUND: There are no primary prevention trials of aspirin with relevant geriatric outcomes in elderly people. ASPirin in Reducing Events in the Elderly (ASPREE) is a placebo-controlled trial of low-dose aspirin that will determine whether 5 years of daily 100-mg enteric-coated aspirin extends di...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Gerontol A Biol Sci Med Sci
Main Authors: McNeil, John J, Woods, Robyn L, Nelson, Mark R, Murray, Anne M, Reid, Christopher M, Kirpach, Brenda, Storey, Elsdon, Shah, Raj C, Wolfe, Rory S, Tonkin, Andrew M, Newman, Anne B, Williamson, Jeff D, Lockery, Jessica E, Margolis, Karen L, Ernst, Michael E, Abhayaratna, Walter P, Stocks, Nigel, Fitzgerald, Sharyn M, Trevaks, Ruth E, Orchard, Suzanne G, Beilin, Lawrence J, Donnan, Geoffrey A, Gibbs, Peter, Johnston, Colin I, Grimm, Richard H
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2017
Assuntos:
The Journal of Gerontology: Medical Sciences
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5861878/
https://ncbi.nlm.nih.gov/pubmed/28329340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/gerona/glw342
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares